April 16, 2020

December 10, 2018

August 4, 2021

UC researchers launched a new study looking treating a common brain problem that results after therapy for cancer.

March 17, 2021

Charles Prestigiacomo, MD, created the Advanced Anatomy of the Head and Neck elective, offered to fourth-year students at the UC College of Medicine who are getting ready to match in surgical residencies and begin performing procedures on patients. He and colleagues are seeing how this class is better preparing students to begin their careers with a little more “real-life” practice.

February 2, 2022

The University of Cincinnati's Chad Zender is leading a clinical trial studying if using a combination of Cesium-131 radioactive seeds and immunotherapy can be more effective and provide better quality of life than current treatments for patients with recurrent head and neck cancer.

May 26, 2023

University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.

December 21, 2020

New UC research shows a dangerous trend in lung cancer caused by the pandemic.

January 11, 2021

COVID-19 vaccine providers across Ohio will soon get better guidance about the next steps for getting shots into arms. Brett Kissela, MD, spoke to WLWT-TV, Channel 5 and said the benefits of the vaccine outweigh any potential side effects.

August 27, 2021

UC research examining a music app to help breast cancer survivors is mentioned by Forbes.

September 23, 2022

The University of Cincinnati's Pankaj Desai, PhD, has received a $1.19 million grant from the National Institutes of Health/National Institute of Neurological Disorders and Stroke to continue research into the use of a drug called letrozole to treat glioblastomas, the most deadly form of brain tumors.

March 24, 2022

The University of Cincinnati is enrolling patients for a new clinical trial testing a two-pronged immunotherapy approach to treat glioblastomas, deadly brain tumors.

August 17, 2020

UC researchers from the College of Medicine and DAAP are working together to see how a music app may help patients who experience "chemobrain."

February 6, 2024

A new University of Cincinnati trial, in partnership with Spark Biomedical, will test a wearable neurostimulation device to help patients with opioid use disorder and post-traumatic stress disorder stick with medication treatment while finding the right dose.